期刊文献+

糖尿病肾病及其候选基因 被引量:3

暂未订购
导出
摘要 糖尿病肾病 (DN)是糖尿病 (DM)常见的微血管并发症之一 ,大量证据表明遗传因素在DN发生发展中起重要作用 ,其发病与基因多态性、基因突变及异常表达等有关 ,本文就目前研究发现的与糖尿病肾病有关的基因作一综述。其主要包括肾素血管紧张素系统的基因如 :血管紧张素Ⅱ 1型受体基因 ;参与非胰岛素依赖的糖代谢相关的基因如 :醛糖还原酶基因、葡萄糖转运蛋白基因 ;与蛋白质代谢相关基因如 :亚甲基四氢叶酸还原酶基因 ;与脂质代谢有关的基因如 :载脂蛋白E基因以及其它相关基因。研究结论不尽一致 ,利用基因芯片等高通量研究手段为深入研究与糖尿病肾病发生发展密切相关的基因提供了有利工具。
出处 《国外医学(泌尿系统分册)》 2004年第3期391-394,共4页 Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
  • 相关文献

参考文献21

  • 1Heesom AE,Hibberd ML,Millward A,et al.Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes.Diabetes,1997,46,287~291
  • 2Shab VO,Scavin M,Nikolic J,et al.Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy.Cl in Endocrinol Metab,1998,83(8),2886
  • 3Park HK,Ahn CW,Lee GT,et al.(AC)n polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus.Diabetes Research and Clinical Practice,2002,55,151~157
  • 4Liu ZH,Guan TJ,Chen ZH,et a1.Glucose transporter allele associated with nephropathy in non-insulin-dependent diabetes mellitus.Kidney Int,1999,55(5),1843
  • 5Hodgkinson AD,Millward BA,Demaine AG.Polymorphisms of the glucose transporter(GLUT1) gene are associated with diabetic nephropathy.Kidney Int,2001,59(3),985~9
  • 6Werle E,Walter F,Christoph H.Apolipoprotein E polymorphism and renal function in german type 1 and type 2 diabetic patients.Diabetes Care,1998,21(6),994~998
  • 7Neugebauer S,Baba T,Watanabe T,et al.Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes.Diabetes,2000,49,500~503
  • 8Howard T,Stephen F,Elyse PM,et al.Chronic diabetic nephropathy:role of inducible nitric oxide synthase.Pediatr Nephrol,2002,17,20~29
  • 9Neugebauer S,Baba T,Watanabe T.Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients.Lancet,1998,352,454
  • 10Smyth JS,Savage DA,Maxwell AP.MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes.Lancet,1999,353(3),1156~1157

二级参考文献3

共引文献17

同被引文献31

  • 1Okada S, Shikata K, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes[J]. Diabetes, 2003 Oct,52(10) :2586.
  • 2Forbes JM, Cooper ME, et al. Role of advanced glycation end products in diabetic nephropathy[J]. J Am Soc Nephrol, 2003,14(8 Suppl 3):S254.
  • 3Omoto S, Nomura S, et al. Significance of platelet-derived microparticles and activated plate lets in diabetic nephropathy[J]. Nephron, 1999,81(3):271.
  • 4Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase:potential relevance in diabetic nephropathy[J]. J Am Soc Nephrol, 2003 Aug, 14(8 Suppl 3):S221.
  • 5Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney[J]. J Am Soc Nephrol, 2003 Aug, 14(8 Suppl 3) :S246.
  • 6Anjaneyulu M, Chopra K. Effect of Irbesartan on the Antioxidant Defence System and Nitric Oxide Release in Diabetic Rat Kidney[J]. Am J Nephrol, 2004 Sep 7,24(5) :488.
  • 7Onozato ML, Tojo A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy:effects of ACEI and ARB[J]. Kidney Int, 2002 Jan,61(1) :186.
  • 8Baricos WH, Cortez SL, el-Dahr SS, et al. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade[J].Kidney Int, 1995,47(4): 1039.
  • 9McLennan SV, Yue DK, Tutle JR. Effect of gulose on matrix metalloproteinase activity in mesangial cells[J]. Nephron, 1998,79:293.
  • 10Chen S, Jim B, et al. Diabetic nephropathy and transforming growth factorbeta: transforming our view of glomerulosclerosis and fibrosis build-up.Ziyadeh FN[J]. Semin Nephrol, 2003 Nov,23(6):532.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部